MicroRNA miR-100 Decreases Glioblastoma Growth by Targeting SMARCA5 and ErbB3 in Tumor-Initiating Cells

Glioblastoma multiforme (GBM) is the most aggressive and most frequently diagnosed malignant human glioma. Despite the best available standard of care (surgery, radiation, and chemotherapy), the median survival of GBM patients is less than 2 years. Many recent studies have indicated that microRNAs (...

Descripción completa

Detalles Bibliográficos
Autores principales: Alrfaei, Bahauddeen M., Clark, Paul, Vemuganti, Raghu, Kuo, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502994/
https://www.ncbi.nlm.nih.gov/pubmed/32945237
http://dx.doi.org/10.1177/1533033820960748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502994/
https://www.ncbi.nlm.nih.gov/pubmed/32945237
http://dx.doi.org/10.1177/1533033820960748

Ejemplares similares